9 Meters Biopharma (NASDAQ:NMTR) Lowered to Hold at Brookline Capital Management : vimarsana.com

Brookline Capital Management downgraded shares of 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) from a buy rating to a hold rating in a report published on Thursday, PriceTargets.com reports. NMTR has been the topic of several other research reports. Truist Financial lowered 9 Meters Biopharma from a buy rating to a hold rating in a […]

Related Keywords

, Meters Biopharma Inc , Meters Biopharma Company Profile , Citigroup , Millennium Management , Renaissance Technologies , Nasdaq , Vanguard Group Inc , Sabby Management , Brookline Capital Management , Get Rating , Street Corp , Biopharma Company , Biopharma Daily , 9 Meters Biopharma , Nasdaq Nmtr , Nmtr , Medical , Downgrade ,